Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xiaoer houerhuan xiaoyan granules
- Development stage
- Unknown
- Lead developer
- Jiangxi Xinglin Baima Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xiaoer Houerhuan Xiaoyan Granules is a pediatric Traditional Chinese Medicine (TCM) formulation primarily composed of the extract from *Archidendron clypearia* (Jack) Nielsen. Developed and manufactured by Jiangxi Xinglin Baima Pharmaceutical Co., Ltd., it is widely used in China for the treatment of acute upper respiratory tract infections, acute tonsillitis, and the common cold in children. The drug is valued for its heat-clearing, detoxifying, and anti-inflammatory properties. Pharmacologically, it functions by inhibiting the production of pro-inflammatory cytokines such as TNF-alpha, IL-6, and IL-1beta, and it exhibits broad-spectrum antimicrobial activity against various respiratory pathogens. It is administered orally as granules, providing a natural therapeutic option for managing pediatric respiratory inflammation and associated symptoms like sore throat and fever.
- Brand names
- Baima
- Other names
- Xiaoer Houerhuan Xiaoyan KeliPediatric Archidendron Clypearia Anti-inflammatory Granules
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on xiaoer houerhuan xiaoyan granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xiaoer houerhuan xiaoyan granules.